Interviews

Wayne Grau, vice president of Legislative Affairs at Managed Health Care Associates, discusses how specialty stakeholders can take steps to improve the perception surrounding specialty pharmacies following recent drug cost controversies.

John Campo, vice president of Pharmacy Trade Relations and Contracting at Managed Health Care Associates discusses how to improve the relationship between specialty pharmacies and specialty drug manufacturers.

Wayne Grau, vice president of Legislative Affairs at Managed Health Care Associates, discusses government action that could influence specialty pharmacy.

Stacey Ness, PharmD, RPh, CSP, MSCS, AAHIVP, senior director of Specialty Clinical Services at Managed Health Care Associates, discusses how specialty pharmacies can navigate limited distribution networks.

Gary Marshall, MD, professor of pediatrics at the University of Louisville School of Medicine, explains how immunization recommendations are made.

Gary Marshall, MD, professor of pediatrics at the University of Louisville School of Medicine, discusses the challenges health care professionals face in implementing vaccine recommendations.

Gary Marshall, MD, professor of pediatrics at the University of Louisville School of Medicine, talks about invasive disease prevention.

Gary Marshall, MD, professor of pediatrics at the University of Louisville School of Medicine, discusses misconceptions about vaccinations.

John Campo, vice president of Pharmacy Trade Relations and Contracting at Managed Health Care Associates discusses how specialty stakeholders can accurately encapsulate the high volume of data they produce to improve operations.

Wayne Grau, vice president of Legislative Affairs at Managed Health Care Associates, discusses the implications of the Medicare Home Infusion Site of Care Act for specialty pharmacy stakeholders.

Stacey Ness, PharmD, RPh, CSP, MSCS, AAHIVP, senior director of Specialty Clinical Services at Managed Health Care Associates, discusses how specialty stakeholders will need to alter current patient management programs as new drugs transform the treatment of diseases into more manageable conditions.

John Campo, vice president of Specialty Pharmacy Trade Relations and Contracting at Managed Health Care Associates, discusses optimal use of data analytics in specialty pharmacy.

Cortney Mospan, PharmD, BCACP, CGP, assistant professor of pharmacy at Wingate University, gives advices to community pharmacists on developing smoking cessation services in pharmacies.

Cortney Mospan, PharmD, BCACP, CGP, assistant professor of pharmacy at Wingate University, talks about how pharmacists can select appropriate smoking cessation therapies for their patients.

Rinku Patel, PharmD, RPh, founder and CEO of KloudScript, discusses the latest trends in the specialty pharmacy landscape.

Cortney Mospan, PharmD, BCACP, CGP, assistant professor of pharmacy at Wingate University, discusses different types of interventions that pharmacists can offer in smoking cessation services.

Cortney Mospan, PharmD, BCACP, CGP, assistant professor of pharmacy at Wingate University, discusses how community pharmacists can structure smoking cessation services.

Paul LeVine, vice president of Analytic Services at TrialCard, discusses how specialty pharmacies can best support patients on a specialty drug therapy.

Sheila Arquette, RPh, director of Pharmacy Services for Independent Health, discusses developments in the specialty pharmacy landscape for stakeholders to monitor.

Mark A. Vineis, vice president of Specialty Pharmacy at Cardinal Health, discusses how the growing population of older Americans could impact the specialty pharmacy landscape.

Kevin James, RPh, MBA, vice president of Payer Strategy at US Bioservices, discusses lessons the specialty industry learned from the impact of high cost drug launches for hepatitis C and high cholesterol.

Erin Hohman, PharmD, BCPS, director of Clinical Pharmacy Services at Amber Pharmacy, discusses the relationship between limited distribution networks and specialty pharmacy.

Autumn Bagwell, PharmD, BCPS, clinical pharmacist at Vanderbilt Specialty Pharmacy, discusses how to address the challenge of access to high cost specialty medications.

Mark Tesell, PharmD, BCPS, clinical consultant pharmacist for UMass Medical School Clinical Pharmacy Services, discusses potential solutions for access to cholesterol lowering drugs to improve.

Suzette DiMascio, CHE, CMCE, CPC, president and CEO of CSI Specialty Group, discusses how specialty pharmacies may need to alter current strategies with increasing attention on high drug costs.

Rebekah L. Hanson, PharmD, BCPS, BCACP, clinical pharmacist and assistant professor at the UIC College of Pharmacy, discusses the challenge of out-of-pocket spending and the impact on drug adherence.

Kevin James, RPh, MBA, vice president of payer strategy at US Bioservices, discusses challenges for patients in accessing specialty medications.

Jonathan Van Lare, PharmD, director of Clinical Services at Pharmacy Advantage, discusses challenges balancing the quality of care with the high cost of treatments.